| Working Paper |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis |
0 |
0 |
0 |
0 |
3 |
3 |
7 |
9 |
| Accounting for the distribution of benefits & costs in benefit-cost analysis |
0 |
0 |
3 |
45 |
2 |
8 |
19 |
115 |
| Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards |
0 |
0 |
0 |
16 |
1 |
2 |
20 |
107 |
| Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards |
0 |
0 |
1 |
120 |
3 |
6 |
19 |
359 |
| Combining Experts’ Judgments: Comparison of Algorithmic Methods using Synthetic Data |
0 |
0 |
0 |
18 |
5 |
8 |
19 |
85 |
| Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year |
0 |
0 |
0 |
27 |
3 |
4 |
18 |
31 |
| Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year |
0 |
0 |
0 |
0 |
1 |
1 |
14 |
15 |
| Contingent Valuation and the Economic Value of Air-Pollution-Related Health Risks in China |
0 |
0 |
2 |
166 |
1 |
5 |
19 |
559 |
| Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness |
0 |
0 |
0 |
12 |
2 |
3 |
12 |
68 |
| Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness |
0 |
0 |
0 |
26 |
2 |
7 |
14 |
87 |
| Dinner with Bayes: On the Revision of Risk Beliefs |
0 |
0 |
0 |
35 |
1 |
3 |
13 |
74 |
| Does risk aversion increase the value of mortality risk? |
0 |
0 |
0 |
3 |
4 |
4 |
10 |
34 |
| Downside Risk Aversion vs Decreasing Absolute Risk Aversion: An Intuitive Exposition |
0 |
0 |
0 |
15 |
3 |
7 |
11 |
25 |
| Downside risk aversion vs decreasing absolute risk aversion: an intuitive exposition |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
6 |
| Economic Evaluation with Hormetic, Hockey-Stick, and Linear Response Functions: An Application to Radon in Drinking Water |
0 |
0 |
0 |
4 |
0 |
3 |
5 |
60 |
| Economic Evaluation with Hormetic, Hockey-Stick, and Linear Response Functions: An Application to Radon in Drinking Water |
0 |
0 |
0 |
7 |
2 |
2 |
4 |
78 |
| Effects of Disease Type and Latency on the Value of Mortality Risk |
0 |
0 |
0 |
84 |
6 |
7 |
12 |
488 |
| Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults |
0 |
0 |
0 |
85 |
5 |
8 |
13 |
214 |
| Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults |
0 |
0 |
0 |
0 |
3 |
4 |
4 |
14 |
| Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults |
0 |
0 |
0 |
5 |
2 |
2 |
9 |
36 |
| Expert Elicitation of the Value per Statistical Life in an Air Pollution Context |
0 |
0 |
0 |
46 |
3 |
5 |
18 |
91 |
| Expert Elicitation of the Value per Statistical Life in an Air Pollution Context |
0 |
0 |
0 |
62 |
1 |
1 |
13 |
231 |
| Fair Innings: An Empirical Test |
0 |
0 |
0 |
13 |
4 |
10 |
24 |
29 |
| Fair Innings? The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime |
0 |
0 |
0 |
14 |
3 |
8 |
14 |
53 |
| Fair Innings? The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime |
0 |
0 |
0 |
3 |
3 |
3 |
9 |
35 |
| Fatality Risk Regulation |
0 |
0 |
0 |
10 |
3 |
4 |
17 |
51 |
| Health Information and Subjective Survival Probability: Evidence from Taiwan |
0 |
0 |
0 |
42 |
3 |
10 |
21 |
286 |
| Health Insurance and Households' Precautionary Behaviors - An Unusual Natural Experiment |
0 |
0 |
0 |
158 |
3 |
4 |
10 |
630 |
| How to Balance Lives and Livelihoods in a Pandemic |
0 |
0 |
0 |
0 |
3 |
3 |
6 |
7 |
| How to Balance Lives and Livelihoods in a Pandemic |
0 |
0 |
0 |
0 |
1 |
2 |
4 |
5 |
| Is Survival a Luxury Good? Income Elasticity of the Value per Statistical Life |
0 |
0 |
0 |
27 |
4 |
5 |
24 |
58 |
| Madison and climate change policy |
0 |
0 |
0 |
0 |
3 |
3 |
4 |
11 |
| Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve |
0 |
0 |
0 |
10 |
3 |
5 |
8 |
20 |
| Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve |
0 |
0 |
0 |
0 |
0 |
0 |
11 |
11 |
| Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys |
0 |
0 |
0 |
0 |
2 |
3 |
5 |
42 |
| Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys |
0 |
0 |
0 |
0 |
0 |
3 |
5 |
20 |
| Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys |
0 |
0 |
0 |
28 |
2 |
2 |
13 |
111 |
| Prevention, Treatment, and Palliative Care: The Relative Value of Health Improvements under Alternative Evaluation Frameworks |
0 |
0 |
0 |
4 |
4 |
5 |
10 |
21 |
| Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks |
0 |
0 |
0 |
0 |
4 |
5 |
13 |
17 |
| Prioritarianism and fatality risk regulation |
0 |
0 |
0 |
0 |
1 |
1 |
5 |
20 |
| Risk and Choice: A Research Saga |
0 |
0 |
0 |
85 |
1 |
5 |
27 |
153 |
| Risk and Choice: A Research Saga |
0 |
0 |
1 |
89 |
1 |
5 |
16 |
144 |
| Risk-Risk Tradeoffs in Fish Consumption: Can You Have the Cake and Eat It Too? |
0 |
0 |
0 |
18 |
2 |
2 |
7 |
68 |
| Statistical vs. Identified Lives in Benefit-Cost Analysis |
0 |
0 |
0 |
21 |
1 |
3 |
13 |
156 |
| Statistical vs. Identified Lives in Benefit-Cost Analysis |
0 |
0 |
0 |
97 |
1 |
3 |
11 |
570 |
| Sub-Saharan Africa Refinery Study |
0 |
0 |
0 |
1 |
3 |
3 |
6 |
7 |
| The Effect of Prenatal Exposure to Radiation on Birth Outcomes: Exploiting a Natural Experiment in Taiwan |
0 |
0 |
0 |
26 |
5 |
10 |
21 |
64 |
| The Intergenerational Transmission of Education: Evidence from Taiwanese Adoptions |
0 |
0 |
0 |
65 |
0 |
2 |
10 |
164 |
| The Intergenerational Transmission of Education: Evidence from Taiwanese Adoptions |
0 |
0 |
0 |
67 |
4 |
5 |
11 |
94 |
| The Modest Effects of Fact Boxes on Cancer Screening |
0 |
0 |
0 |
0 |
2 |
4 |
12 |
14 |
| The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair |
0 |
0 |
0 |
0 |
0 |
0 |
5 |
5 |
| The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair |
0 |
0 |
0 |
0 |
0 |
1 |
2 |
2 |
| The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach |
0 |
0 |
0 |
55 |
6 |
7 |
11 |
88 |
| The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach |
0 |
0 |
0 |
27 |
4 |
4 |
10 |
124 |
| The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach |
0 |
0 |
0 |
47 |
2 |
2 |
7 |
142 |
| The Value of Cancer Prevention vs Treatment |
0 |
0 |
0 |
44 |
2 |
9 |
20 |
169 |
| The Value of Risk Reduction: New Tools for an Old Problem |
0 |
0 |
0 |
110 |
10 |
11 |
24 |
196 |
| The Welfare Value of FDA’s Mercury-in-Fish Advisory: A Dynamic Reanalysis |
0 |
0 |
0 |
15 |
1 |
4 |
12 |
192 |
| The economics in 'Global Health 2035': a sensitivity analysis of the value of a life year estimates |
0 |
0 |
0 |
53 |
2 |
2 |
11 |
62 |
| The value of disease prevention vs treatment |
0 |
0 |
0 |
0 |
2 |
4 |
12 |
23 |
| The value of disease prevention vs treatment |
0 |
0 |
0 |
0 |
1 |
2 |
4 |
29 |
| The value of risk reduction: new tools for an old problem |
0 |
0 |
0 |
0 |
0 |
3 |
10 |
38 |
| Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates |
0 |
0 |
0 |
1 |
1 |
1 |
1 |
6 |
| Valuation of the Risk of SARS in Taiwan |
0 |
0 |
0 |
94 |
0 |
4 |
6 |
419 |
| Valuing COVID-19 Morbidity Risk Reductions |
0 |
0 |
0 |
0 |
1 |
2 |
5 |
8 |
| Valuing Children’s Fatality Risk Reductions |
0 |
0 |
0 |
31 |
0 |
1 |
6 |
36 |
| Valuing Morbidity Risk: Willingness to Pay per Quality-Adjusted Life Year |
0 |
0 |
0 |
33 |
1 |
3 |
10 |
115 |
| Valuing Mortality Risk Reductions: Progress and Challenges |
0 |
0 |
0 |
45 |
2 |
2 |
8 |
138 |
| Valuing Mortality Risk Reductions: Progress and Challenges |
0 |
0 |
0 |
57 |
0 |
4 |
13 |
122 |
| Valuing Mortality Risk Reductions:Progress and Challenges |
0 |
0 |
0 |
7 |
1 |
3 |
9 |
119 |
| Valuing Mortality Risk in China: Comparing Stated-Preference Estimates from 2005 and 2016 |
0 |
0 |
0 |
33 |
2 |
3 |
11 |
92 |
| Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures |
0 |
0 |
0 |
50 |
3 |
3 |
11 |
60 |
| Valuing mortality risk in the time of covid-19 |
0 |
0 |
1 |
38 |
3 |
10 |
25 |
99 |
| Valuing non-marginal changes in mortality and morbidity risk |
0 |
0 |
0 |
5 |
4 |
7 |
23 |
34 |
| Valuing non-marginal changes in mortality and morbidity risk |
0 |
0 |
0 |
0 |
1 |
1 |
10 |
13 |
| Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety |
0 |
0 |
0 |
5 |
3 |
4 |
10 |
71 |
| Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety |
0 |
0 |
0 |
29 |
3 |
5 |
14 |
160 |
| Willingness to Pay for Car Safety: Sensitivity to Time Framing |
0 |
0 |
0 |
38 |
0 |
2 |
13 |
183 |
| Willingness to pay and QALYs: What can we learn about valuing foodborne risk? |
0 |
0 |
0 |
38 |
0 |
2 |
8 |
141 |
| Willingness to pay and QALYs: What can we learn about valuing foodborne risk? |
0 |
0 |
0 |
10 |
7 |
7 |
14 |
73 |
| Total Working Papers |
0 |
0 |
8 |
2,419 |
182 |
327 |
938 |
8,606 |
| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Benefit‐Cost Analysis of Retrofitting Diesel Vehicles with Particulate Filters in the Mexico City Metropolitan Area |
0 |
0 |
1 |
3 |
0 |
2 |
8 |
16 |
| A Comparison of Organic and Conventional Fresh Produce Buyers in the Boston Area |
0 |
0 |
0 |
6 |
0 |
1 |
7 |
26 |
| A Theoretical Foundation for Life‐Cycle Assessment: Recognizing the Role of Values in Environmental Decision Making |
0 |
0 |
2 |
11 |
1 |
2 |
9 |
21 |
| A new meta-analysis on the WTP/WTA disparity |
0 |
0 |
1 |
141 |
2 |
8 |
24 |
477 |
| Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis |
0 |
0 |
0 |
4 |
3 |
5 |
20 |
40 |
| Adding an Economic Dimension to Risk Assessment: Discussion |
0 |
0 |
0 |
10 |
1 |
1 |
5 |
28 |
| Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures |
0 |
0 |
1 |
32 |
0 |
0 |
4 |
124 |
| Aggregation Biases in Estimates of the Value per Statistical Life: Evidence from Longitudinal Matched Worker-Firm Data in Taiwan |
0 |
0 |
0 |
21 |
1 |
2 |
8 |
102 |
| Are The Costs of Proposed Environmental Regulations Overestimated? Evidence from the CFC Phaseout |
0 |
1 |
1 |
54 |
0 |
1 |
7 |
206 |
| Assessing Preferences for Prevention versus Treatment Using Willingness to Pay |
0 |
0 |
0 |
1 |
0 |
0 |
1 |
4 |
| Attention to Distribution in U.S. Regulatory Analyses |
0 |
0 |
0 |
9 |
2 |
3 |
12 |
52 |
| Background Risks and the Value of a Statistical Life |
0 |
0 |
0 |
69 |
1 |
3 |
9 |
247 |
| Behavioral Economics and Regulatory Analysis |
0 |
0 |
0 |
3 |
3 |
3 |
7 |
25 |
| Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards |
1 |
1 |
3 |
77 |
1 |
4 |
17 |
244 |
| Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards |
0 |
0 |
1 |
10 |
0 |
2 |
10 |
49 |
| Combining Experts’ Judgments: Comparison of Algorithmic Methods Using Synthetic Data |
0 |
0 |
0 |
0 |
1 |
7 |
14 |
26 |
| Compensating Wage Differentials with Unemployment: Evidence from China |
0 |
0 |
0 |
56 |
2 |
6 |
18 |
201 |
| Computer use and wages: evidence from Taiwan |
0 |
0 |
0 |
42 |
2 |
5 |
11 |
200 |
| Conducting Benefit-Cost Analysis in Low- and Middle-Income Countries: Introduction to the Special Issue |
0 |
0 |
0 |
17 |
0 |
0 |
4 |
43 |
| Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year |
0 |
0 |
0 |
0 |
4 |
6 |
15 |
18 |
| Consumer Willingness to Pay for Low‐Pesticide Fresh Produce in Taiwan |
0 |
0 |
0 |
66 |
3 |
5 |
14 |
198 |
| Consumer’s Guide to Regulatory Impact Analysis: Ten Tips for Being an Informed Policymaker |
0 |
0 |
0 |
3 |
2 |
3 |
7 |
22 |
| Contingent valuation of a Taiwanese wetland |
0 |
0 |
2 |
132 |
2 |
2 |
9 |
316 |
| DISCOUNTING HEALTH AND COST‐EFFECTIVENESS ANALYSIS: A RESPONSE TO NORD |
0 |
0 |
0 |
1 |
2 |
2 |
8 |
39 |
| Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
8 |
| Dinner with Bayes: On the revision of risk beliefs |
0 |
0 |
0 |
3 |
0 |
0 |
14 |
48 |
| Discounting health increments |
0 |
0 |
0 |
12 |
1 |
1 |
5 |
55 |
| Do small plants grow faster? Evidence from the Taiwan electronics industry |
0 |
0 |
0 |
85 |
1 |
4 |
15 |
414 |
| Does risk aversion increase the value of mortality risk? |
0 |
0 |
0 |
44 |
3 |
3 |
7 |
202 |
| Downside risk aversion vs decreasing absolute risk aversion: an intuitive exposition |
0 |
0 |
0 |
3 |
4 |
6 |
12 |
20 |
| EXPORTING AND PRODUCTIVITY GROWTH: EVIDENCE FROM THE TAIWAN ELECTRONICS PLANTS |
0 |
0 |
0 |
31 |
3 |
6 |
13 |
131 |
| Effects of Disease Type and Latency on the Value of Mortality Risk |
0 |
0 |
1 |
35 |
1 |
2 |
9 |
259 |
| Effects of Health and Longevity on Financial Risk Tolerance |
0 |
0 |
0 |
4 |
2 |
2 |
7 |
30 |
| Environmental false alarms and policy implications |
0 |
0 |
0 |
8 |
2 |
2 |
3 |
24 |
| Equity, Efficiency, Uncertainty, and the Mitigation of Global Climate Change |
0 |
0 |
0 |
1 |
1 |
2 |
6 |
11 |
| Erratum to: Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety |
0 |
0 |
0 |
2 |
0 |
1 |
13 |
36 |
| Estimated hedonic wage function and value of life in a developing country |
0 |
1 |
4 |
194 |
0 |
3 |
14 |
601 |
| Estimating General-population Utilities Using One Binary-gamble Question per Respondent |
0 |
0 |
0 |
0 |
1 |
1 |
6 |
7 |
| Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults |
0 |
0 |
0 |
3 |
2 |
4 |
5 |
42 |
| Expert Elicitation of the Value per Statistical Life in an Air Pollution Context |
0 |
0 |
0 |
2 |
2 |
3 |
17 |
43 |
| Export activity and productivity: Evidence from the Taiwan electronics industry |
0 |
0 |
0 |
76 |
5 |
8 |
19 |
286 |
| Extrapolating the Value Per Statistical Life Between Populations: Theoretical Implications |
0 |
0 |
0 |
5 |
0 |
0 |
3 |
28 |
| Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime |
0 |
0 |
0 |
0 |
4 |
7 |
19 |
37 |
| Family background and returns to schooling in Taiwan |
0 |
0 |
0 |
39 |
1 |
4 |
18 |
145 |
| Finding the Optimal Multiple-test Strategy Using a Method Analogous to Logistic Regression |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
5 |
| From Benefit–Cost Analysis to Social Welfare: A Pragmatic Approach |
0 |
2 |
4 |
4 |
3 |
7 |
14 |
14 |
| Health Information and Subjective Survival Probability: Evidence from Taiwan |
0 |
0 |
0 |
0 |
2 |
4 |
10 |
54 |
| Households’ precautionary behaviors—the effects of the introduction of National Health Insurance in Taiwan |
0 |
0 |
0 |
48 |
3 |
7 |
14 |
194 |
| Hurricane risk perceptions and housing market responses: the pricing effects of risk-perception factors and hurricane characteristics |
0 |
1 |
2 |
12 |
2 |
5 |
11 |
42 |
| Implications of the WTP–WTA Disparity for Benefit–Cost Analysis |
1 |
1 |
1 |
14 |
2 |
3 |
5 |
42 |
| Introduction to Special Issue on Life Cycle Assessment and Risk Analysis |
0 |
0 |
0 |
0 |
1 |
1 |
5 |
14 |
| Introduction to the Special Series on Research Synthesis: A Cross‐Disciplinary Approach |
0 |
0 |
0 |
0 |
1 |
2 |
6 |
12 |
| Introduction to the Special Series on Risk, Perception, and Response |
0 |
0 |
0 |
0 |
1 |
2 |
4 |
5 |
| Is survival a luxury good? Income elasticity of the value per statistical life |
0 |
0 |
0 |
3 |
2 |
4 |
11 |
30 |
| Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis |
0 |
0 |
0 |
0 |
2 |
2 |
6 |
9 |
| Limitations to Empirical Extrapolation Studies: The Case of BMD Ratios |
0 |
0 |
0 |
0 |
1 |
1 |
6 |
9 |
| Major Factors Influencing the Health Impacts from Controlling Air Pollutants with Nonlinear Chemistry: An Application to China |
0 |
0 |
0 |
0 |
1 |
2 |
7 |
11 |
| Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children |
0 |
0 |
1 |
57 |
2 |
2 |
6 |
203 |
| Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve |
0 |
0 |
0 |
0 |
3 |
3 |
15 |
19 |
| Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan |
0 |
0 |
0 |
4 |
3 |
4 |
14 |
218 |
| National Health Insurance and Technology Adoption: Evidence from Taiwan |
0 |
0 |
0 |
30 |
2 |
3 |
12 |
157 |
| National Health Insurance and precautionary saving: evidence from Taiwan |
0 |
1 |
1 |
217 |
1 |
6 |
17 |
632 |
| Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys |
0 |
0 |
1 |
8 |
5 |
8 |
22 |
109 |
| Perceived Risks of Conventional and Organic Produce: Pesticides, Pathogens, and Natural Toxins |
0 |
0 |
0 |
8 |
2 |
2 |
6 |
28 |
| Perceived risk and value of workplace safety in a developing country |
0 |
0 |
2 |
16 |
4 |
4 |
17 |
81 |
| Positive versus Normative Justifications for Benefit-Cost Analysis: Implications for Interpretation and Policy |
0 |
0 |
2 |
59 |
2 |
8 |
25 |
199 |
| Precautionary Regulation in Europe and the United States: A Quantitative Comparison |
0 |
0 |
0 |
2 |
1 |
2 |
6 |
47 |
| Preferences for life-expectancy gains: Sooner or later? |
0 |
0 |
0 |
15 |
1 |
4 |
8 |
74 |
| Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks |
0 |
0 |
0 |
1 |
4 |
10 |
14 |
26 |
| Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks |
0 |
0 |
0 |
1 |
0 |
1 |
5 |
12 |
| Pricing Lives: Guideposts for a Safer Society. W. Kip Viscusi (2018). Princeton, NJ: Princeton University Press |
0 |
0 |
1 |
23 |
4 |
5 |
8 |
49 |
| Principles for Conduct of Pest Risk Analyses: Report of an Expert Work hop |
0 |
0 |
0 |
2 |
3 |
3 |
8 |
15 |
| QALYs Versus WTP |
0 |
0 |
2 |
11 |
2 |
2 |
11 |
39 |
| Research Synthesis and the Value per Statistical Life |
0 |
0 |
0 |
11 |
0 |
3 |
12 |
53 |
| Residential Building Codes, Affordability, and Health Protection: A Risk‐Tradeoff Approach |
0 |
0 |
0 |
0 |
2 |
4 |
15 |
21 |
| Risk Perceptions and Food Choice: An Exploratory Analysis of Organic‐ Versus Conventional‐Produce Buyers |
0 |
0 |
0 |
5 |
3 |
3 |
12 |
30 |
| Risk Premiums for Environmental Liability: Does Superfund Increase the Cost of Capital? |
0 |
1 |
1 |
58 |
4 |
6 |
15 |
206 |
| Risk and choice: A research saga |
0 |
0 |
1 |
65 |
1 |
2 |
12 |
213 |
| Risk/Risk Trade‐offs in Pesticide Regulation: An Exploratory Analysis of the Public Health Effects of a Ban on Organophosphate and Carbamate Pesticides |
0 |
0 |
0 |
1 |
0 |
1 |
8 |
18 |
| Safety Impacts of SUVs, Vans, and Pickup Trucks in Two‐Vehicle Crashes |
0 |
0 |
0 |
3 |
0 |
0 |
4 |
23 |
| Selecting Human Health Metrics for Environmental Decision‐Support Tools |
0 |
0 |
0 |
0 |
2 |
3 |
5 |
12 |
| Sensitivity of willingness to pay to the magnitude of risk reduction: a TaiwanUnited States comparison |
0 |
0 |
0 |
3 |
3 |
6 |
17 |
42 |
| Skills of the trade: valuing health risk reductions in benefit-cost analysis |
0 |
0 |
0 |
4 |
4 |
4 |
12 |
42 |
| Skills of the trade: valuing health risk reductions in benefit-cost analysis |
0 |
0 |
0 |
33 |
3 |
3 |
12 |
134 |
| Statistical Analysis of Cost-Effectiveness Data by A. R. WILLAN, and A. H. BRIGGS |
0 |
0 |
0 |
1 |
0 |
0 |
2 |
16 |
| Statistical vs. identified lives in benefit-cost analysis |
0 |
0 |
0 |
46 |
0 |
1 |
14 |
282 |
| Subjective‐Probability‐Based Scenarios for Uncertain Input Parameters: Stratospheric Ozone Depletion |
0 |
0 |
0 |
0 |
0 |
3 |
9 |
17 |
| The Economic Value of Air-Pollution-Related Health Risks in China: A Contingent Valuation Study |
0 |
0 |
0 |
169 |
1 |
4 |
12 |
650 |
| The Expected Value of Information and the Probability of Surprise |
0 |
0 |
0 |
3 |
1 |
1 |
4 |
20 |
| The Impact of Advanced Technology Adoption on Wage Structures: Evidence from Taiwan Manufacturing Firms |
0 |
0 |
1 |
2 |
3 |
3 |
10 |
19 |
| The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations |
0 |
0 |
1 |
8 |
3 |
10 |
34 |
70 |
| The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations |
0 |
0 |
1 |
88 |
6 |
15 |
36 |
407 |
| The Long-Run Discount Rate Controversy |
0 |
0 |
4 |
47 |
5 |
9 |
23 |
183 |
| The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair |
0 |
0 |
1 |
1 |
2 |
2 |
6 |
6 |
| The changing risk perception towards nuclear power in China after the Fukushima nuclear accident in Japan |
0 |
1 |
1 |
9 |
4 |
6 |
11 |
53 |
| The economic value of fatal and non‐fatal occupational risks in Mexico City using actuarial‐ and perceived‐risk estimates |
1 |
1 |
3 |
58 |
2 |
3 |
7 |
231 |
| The effect of prenatal exposure to radiation on birth outcomes: exploiting a natural experiment in Taiwan |
0 |
0 |
1 |
7 |
1 |
3 |
11 |
49 |
| The future costs of methane emissions |
0 |
0 |
0 |
0 |
4 |
4 |
8 |
16 |
| The impact of foreign direct investment in China on employment adjustments in Taiwan: Evidence from matched employer–employee data |
0 |
0 |
0 |
54 |
7 |
7 |
18 |
262 |
| The intergenerational transmission of education: Evidence from Taiwanese adoptions |
0 |
0 |
0 |
23 |
3 |
3 |
17 |
97 |
| The modest effects of fact boxes on cancer screening |
0 |
0 |
0 |
2 |
4 |
5 |
14 |
23 |
| The price elasticity of opium in Taiwan, 1914-1942 |
0 |
0 |
0 |
58 |
1 |
1 |
26 |
234 |
| The social value of mortality risk reduction: VSL versus the social welfare function approach |
0 |
0 |
0 |
8 |
3 |
6 |
16 |
80 |
| The value of disease prevention vs treatment |
0 |
0 |
0 |
22 |
2 |
3 |
7 |
84 |
| The value of international cooperation for abating global climate change |
0 |
0 |
0 |
26 |
0 |
2 |
13 |
128 |
| The value of risk reduction: new tools for an old problem |
0 |
0 |
1 |
11 |
0 |
2 |
15 |
72 |
| The welfare value of FDA's mercury-in-fish advisory: A dynamic reanalysis |
0 |
0 |
0 |
5 |
3 |
3 |
10 |
88 |
| Theoretical bounds on the value of improved health |
0 |
0 |
1 |
6 |
4 |
7 |
19 |
45 |
| Tiered Chemical Testing: A Value of Information Approach |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
5 |
| Tools for Comparative Analysis of Alternatives: Competing or Complementary Perspectives? |
0 |
0 |
0 |
0 |
2 |
2 |
12 |
20 |
| Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates |
0 |
0 |
0 |
1 |
2 |
2 |
5 |
11 |
| Understanding differences in estimates of the value of mortality risk |
0 |
0 |
0 |
5 |
0 |
0 |
3 |
21 |
| Use of Contingent Valuation to Elicit Willingness-to-Pay for the Benefits of Developmental Health Risk Reductions |
0 |
0 |
0 |
40 |
1 |
2 |
8 |
124 |
| Using Life Expectancy to Communicate Benefits of Health Care Programs in Contingent Valuation Studies |
0 |
0 |
0 |
0 |
2 |
3 |
5 |
5 |
| Valuation of the risk of SARS in Taiwan |
0 |
0 |
0 |
38 |
3 |
3 |
4 |
254 |
| Valuing COVID-19 Morbidity Risk Reductions |
0 |
0 |
0 |
1 |
0 |
1 |
6 |
11 |
| Valuing Changes in Mortality Risk: Lives Saved Versus Life Years Saved |
0 |
1 |
1 |
45 |
2 |
5 |
8 |
155 |
| Valuing Children’s Fatality Risk Reductions |
0 |
0 |
0 |
3 |
0 |
1 |
7 |
19 |
| Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis |
0 |
0 |
0 |
16 |
3 |
4 |
12 |
61 |
| Valuing Mortality Risk Reductions: Progress and Challenges |
0 |
0 |
3 |
33 |
3 |
3 |
18 |
205 |
| Valuing Mortality-Risk Reduction: Using Visual Aids to Improve the Validity of Contingent Valuation |
0 |
1 |
1 |
122 |
3 |
4 |
15 |
625 |
| Valuing Non-Fatal Health Risks: Monetary and Health-Utility Measures |
0 |
0 |
0 |
0 |
3 |
5 |
8 |
22 |
| Valuing Reductions in Fatal Illness Risks: Implications of Recent Research |
0 |
1 |
6 |
24 |
0 |
2 |
15 |
80 |
| Valuing fatal risks to children and adults: Effects of disease, latency, and risk aversion |
1 |
1 |
3 |
92 |
1 |
4 |
22 |
287 |
| Valuing mortality risk in China: Comparing stated-preference estimates from 2005 and 2016 |
0 |
1 |
1 |
14 |
1 |
4 |
10 |
78 |
| Valuing mortality risk in the time of COVID-19 |
0 |
0 |
0 |
6 |
4 |
7 |
15 |
62 |
| Valuing non-marginal changes in mortality and morbidity risk |
0 |
0 |
0 |
1 |
1 |
3 |
8 |
13 |
| Valuing nonfatal health risk as a function of illness severity and duration: Benefit transfer using QALYs |
0 |
0 |
1 |
34 |
3 |
5 |
20 |
109 |
| Valuing the Risk of Death from Terrorist Attacks |
0 |
0 |
0 |
2 |
3 |
4 |
14 |
30 |
| Willingness to Pay and QALYs: What Can We Learn about Valuing Foodborne Risk? |
0 |
0 |
0 |
3 |
3 |
3 |
14 |
55 |
| Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety |
1 |
1 |
1 |
7 |
4 |
6 |
17 |
85 |
| Willingness to Pay for Food Safety: Sensitivity to Duration and Severity of Illness |
0 |
0 |
0 |
74 |
0 |
2 |
6 |
191 |
| Willingness to Pay for Health Protection: Inadequate Sensitivity to Probability? |
0 |
0 |
2 |
135 |
0 |
1 |
10 |
365 |
| Willingness to pay for weight-control treatment |
0 |
0 |
0 |
43 |
2 |
4 |
13 |
170 |
| Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents |
0 |
0 |
0 |
1 |
4 |
5 |
10 |
72 |
| Worker flows and job flows in Taiwan |
0 |
0 |
0 |
14 |
5 |
5 |
17 |
93 |
| Worker turnover and job reallocation in Taiwanese manufacturing |
0 |
0 |
0 |
29 |
4 |
4 |
9 |
190 |
| Total Journal Articles |
5 |
17 |
70 |
3,471 |
267 |
473 |
1,533 |
14,844 |
LogEc is hosted by the
Örebro University School of Business.